Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy ... rights to Jazz Pharma's dual-acting dopamine and norepinephrine reuptake inhibitor Sunosi (solriamfetol ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

A: Almost a decade ago, the FDA approved two new drugs to lower LDL ... It is a serotonin-norepinephrine reuptake inhibitor (SNRI). When I took it for two years, my gut motility eventually shut ...

The FDA approval is the latest bold advance in the emerging field of theranostics, which uses radioactive substances to visualize cancer cells and destroy them without harming normal cells. It also ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.